News & Updates

Long-term TAF works against resistant HBV, poses no excess cardiovascular risk

17 Nov 2021 by

Tenofovir alafenamide (TAF) shows sustained safety and efficacy in heavily pretreated patients with multidrug-resistant hepatitis B virus (HBV) through 3 years of treatment, albeit leading to elevations in cholesterol levels.

Long-term TAF works against resistant HBV, poses no excess cardiovascular risk

17 Nov 2021

Insulin hypersecretion, not resistance, tied to arterial stiffness in young adults

17 Nov 2021

Postloading insulinaemia appears to be linked to arterial stiffness in young individuals, a recent Japan study has found. In contrast, insulin sensitivity (SI) shows no such effect.

Insulin hypersecretion, not resistance, tied to arterial stiffness in young adults

17 Nov 2021

Pacemaker-based cardiac neuromodulation therapy lowers SBP, pulse pressure in patients with ISH

17 Nov 2021 by

Adding BackBeat cardiac neuromodulation therapy™ (Backbeat CNT), a pacemaker-based treatment for hypertension, on top of medical therapy significantly reduces systolic blood pressure (SBP) and pulse pressure, without reducing diastolic blood pressure (DBP), compared with medical therapy alone in patients with isolated systolic hypertension (ISH), according to a study presented at TCT 2021.

Pacemaker-based cardiac neuromodulation therapy lowers SBP, pulse pressure in patients with ISH

17 Nov 2021

High baseline leptin linked to arterial stiffening in men

16 Nov 2021

High levels of circulating leptin may be a risk factor for arterial stiffening and elevated pulse pressure in men, regardless of body weight, a recent study has found.

High baseline leptin linked to arterial stiffening in men

16 Nov 2021

SURTAVI: TAVR matches SAVR through 5 years in intermediate-risk AS patients

16 Nov 2021 by

The noninferiority finding between transcatheter vs surgical aortic valve replacement (TAVR vs SAVR) in intermediate-risk patients with severe aortic stenosis (AS) holds up through 5 years, according to long-term data of the SURTAVI trial presented at TCT 2021, providing reassurance that the less invasive procedure performs just as good in the elderly population.

SURTAVI: TAVR matches SAVR through 5 years in intermediate-risk AS patients

16 Nov 2021

TiNO-coated stent maintains edge over drug-eluting stent for ACS

16 Nov 2021 by

The 3-year outcomes of the TIDES-ACS* trial continued to reflect favourable outcomes with the titanium-nitride-oxide (TiNO)-coated bioactive stent compared with a platinum-chromium-based biodegradable-polymer everolimus-eluting stent (EES) for patients with acute coronary syndrome (ACS).

TiNO-coated stent maintains edge over drug-eluting stent for ACS

16 Nov 2021

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes

16 Nov 2021 by

A study by the University of Hong Kong (HKU) has revealed a causal link between better lung function and reduced risk of coronary artery disease (CAD), stroke and type 2 diabetes mellitus (T2DM).

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes

16 Nov 2021

LVAD-specific infections common after heart transplant

15 Nov 2021 by

While left ventricular assist device (LVAD)-specific infections (LSI) are common among patients undergoing heart transplant (HTs), they seem to have no impact on postsurgical outcomes, according to a recent study.

LVAD-specific infections common after heart transplant

15 Nov 2021

Statins tied to higher risk of diabetes progression

14 Nov 2021 by

Statin therapy is associated with an excess risk of diabetes progression, including increased likelihood of poor glycaemic control, need for treatment escalation, and hyperglycaemic complications, a cohort study has found.

Statins tied to higher risk of diabetes progression

14 Nov 2021

Statin confers cardioprotection, survival benefit for middle-aged, older diabetics

14 Nov 2021

Statin reduces the risk of cardiovascular disease and mortality in type 2 diabetes, and this beneficial effect is evident among middle-aged and, to a lesser extent, older patients but not among young patients, a study has found.

Statin confers cardioprotection, survival benefit for middle-aged, older diabetics

14 Nov 2021

News & Updates

Filter by Specialty:

Specialty:

Long-term TAF works against resistant HBV, poses no excess cardiovascular risk

Long-term TAF works against resistant HBV, poses no excess cardiovascular risk

Insulin hypersecretion, not resistance, tied to arterial stiffness in young adults

Insulin hypersecretion, not resistance, tied to arterial stiffness in young adults

Pacemaker-based cardiac neuromodulation therapy lowers SBP, pulse pressure in patients with ISH

Pacemaker-based cardiac neuromodulation therapy lowers SBP, pulse pressure in patients with ISH

High baseline leptin linked to arterial stiffening in men

High baseline leptin linked to arterial stiffening in men

SURTAVI: TAVR matches SAVR through 5 years in intermediate-risk AS patients

SURTAVI: TAVR matches SAVR through 5 years in intermediate-risk AS patients

TiNO-coated stent maintains edge over drug-eluting stent for ACS

TiNO-coated stent maintains edge over drug-eluting stent for ACS

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes

Better lung function may protect against coronary artery disease, stroke and type 2 diabetes

LVAD-specific infections common after heart transplant

LVAD-specific infections common after heart transplant

Statins tied to higher risk of diabetes progression

Statins tied to higher risk of diabetes progression

Statin confers cardioprotection, survival benefit for middle-aged, older diabetics

Statin confers cardioprotection, survival benefit for middle-aged, older diabetics